Practical Question: Continuous Freedom to Operate. Keeping an Inhaled RNA Platform Clear to Market with Benjamin Winkeljann

Developing an inhaled RNA therapy requires a company to bring several technologies together: the therapeutic RNA, its carrier, the formulation, the manufacturing process and the delivery device. As these elements become a defined product, they also cr ...

Read More